The CSB Biofoundry, a new resource launched by Northwestern’s Center for Synthetic Biology, welcomed researchers and startups to its first Open House last week. The facility, located at 1801 Maple … Continued
One of the most exciting areas of innovation in the biotech sector in recent years has been the development of novel gene-delivery vehicles used in cell- and gene-based therapies. However, … Continued
Pearl Bio was spun out of research from Farren Isaacs, Ph.D., and Michael Jewett, Ph.D., that centers on using ”genomically recoded organisms” to add synthetic chemistry to biologics.
New Farley Center course leverages case studies and expert guest speakers to explore commercial innovation in the fast-moving synthetic biology industry.
Translating exciting discoveries into next-generation technologies fuels the mission of the Center for Synthetic Biology (CSB) at Northwestern. Since its inception in 2016, the CSB has produced several start-up companies … Continued
